Doll Jacob A, Ohman E Magnus, Patel Manesh R, Milano Carmelo A, Rogers Joseph G, Wohns David H, Kapur Navin K, Rao Sunil V
Duke University Medical Center, Durham, North Carolina.
the Duke Clinical Research Institute, Durham, North Carolina.
Catheter Cardiovasc Interv. 2016 Sep;88(3):424-33. doi: 10.1002/ccd.26297. Epub 2015 Nov 3.
Cardiogenic shock is a common clinical condition with high in-hospital mortality. Early application of appropriate interventions for cardiogenic shock-including medical therapies, revascularization, temporary hemodynamic support devices, and durable mechanical circulatory support-may improve outcomes. The number and complexity of therapies for cardiogenic shock are increasing, making time-dependent decision-making more challenging. A multidisciplinary cardiogenic shock team is recommended to guide the rapid and efficient use of these available treatments. © 2015 Wiley Periodicals, Inc.
心源性休克是一种常见的临床病症,院内死亡率很高。早期对心源性休克应用适当的干预措施,包括药物治疗、血运重建、临时血流动力学支持装置和持久性机械循环支持,可能会改善预后。治疗心源性休克的疗法数量和复杂性都在增加,这使得依赖时间的决策变得更具挑战性。建议成立一个多学科的心源性休克治疗团队,以指导这些现有治疗方法的快速有效使用。© 2015威利期刊公司。